1j2n: Difference between revisions

Revision as of 14:24, 1 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1j2n.png

Template:STRUCTURE 1j2n

Solution structure of CPI-17(22-120) T38DSolution structure of CPI-17(22-120) T38D

Template:ABSTRACT PUBMED 12595264

About this StructureAbout this Structure

1J2N is a Single protein structure of sequence from Sus scrofa. Full experimental information is available from OCA.

ReferenceReference

Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue., Ohki S, Eto M, Shimizu M, Takada R, Brautigan DL, Kainosho M, J Mol Biol. 2003 Mar 7;326(5):1539-47. PMID:12595264

Page seeded by OCA on Tue Jul 1 14:24:31 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1j2n.jpg|left|200px]]
+{{Seed}}
+[[Image:1j2n.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1j2n|  PDB=1j2n  |  SCENE=  }}
-'''Solution structure of CPI-17(22-120) T38D'''
+===Solution structure of CPI-17(22-120) T38D===
-==Overview==
+<!--
-We present solution NMR structures for wild-type and mutated forms of CPI-17, a phosphoinhibitor for protein phosphatase 1. Phosphorylation of Thr38 of CPI-17 produces a &gt;1000-fold increase in inhibitory potency for myosin phosphatase. We compared the 1H-15N heteronuclear single quantum coherence spectroscopy (HSQC) chemical shifts of wild-type CPI-17, partially phosphorylated CPI-17 and CPI-17 with Thr38 replaced with Asp to introduce a negative charge. There was a switch in the protein conformation due to either Asp substitution or phosphorylation, so we determined the solution NMR structure of the CPI-17 T38D mutant as a model for the active (phospho-) conformation. The structures reveal a molecular switch in conformation that involves the rotation of two of the four helices in the four helix bundle. Despite this conformational switch, there was little increase in the inhibitory potency with T38D. We propose that for this inhibitor, a negative charge at residue 38 is sufficient to trigger an active conformation, but a phosphoryl group is required for full inhibitory potency against protein phosphatase-1.
+The line below this paragraph, {{ABSTRACT_PUBMED_12595264}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 12595264 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_12595264}}
 ==About this Structure==
-J2N is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Sus_scrofa Sus scrofa]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1J2N OCA].
+J2N is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Sus_scrofa Sus scrofa]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1J2N OCA].
 ==Reference==
@@ Line 29: / Line 33: @@
 [[Category: Takada, R.]]
 [[Category: Helix bundle]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 20:43:43 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul  1 14:24:31 2008''